Evidence map›Paper›PMID 40587029›Full record

GuidelineClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Spanish Society for Radiation Oncology and Spanish Society of Medical Physicists recommendations on reirradiation in gynecological cancer: reirradiation techniques, survival outcomes, dose, and toxicity.

Dina Najjari-Jamal, Sofia Cordoba, Marta Gimeno-Morales, Diana Guevara, Katarina Majercakova, Maria Sanchez, Sonia Garcia-Cabezas, Soraya Mico, Natalia Tejedor, Clara Navarro and 6 more

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dina Najjari-JamalRadiation Oncology Department, Catalan Institute of Oncology (ICO), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. dnajjari@iconcologia.net.ORCID http://orcid.org/0000-0001-7815-2870
Sofia CordobaRadiation Oncology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Marta Gimeno-MoralesRadiation Oncology Department, Cancer Center Clinica, Universidad de Navarra, University of Navarre, Madrid, Pamplona, Spain.
Diana GuevaraRadiation Oncology Department, Clinica Benidorm Hospital, Benidorm, Alicante, Spain.
Katarina MajercakovaRadiation Oncology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Maria SanchezRadiation Oncology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Sonia Garcia-CabezasRadiation Oncology Department, Reina Sofía University Hospital, Córdoba, Spain.
Soraya MicoRadiation Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Natalia TejedorMedical Physics Department, Hospital Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Clara NavarroMedical Physics Department, Toledo University Hospital, Toledo, Spain.
Fernando CerronMedical Physics Department, Hospital Quirón Salud, Madrid, Spain.
Francisco PinoRadiation Oncology Department, Catalan Institute of Oncology (ICO), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Teresa MuñozRadiation Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
Miguel Angel BerenguerRadiation Oncology Department, Hospital Universitario La Fe, Valencia, Spain.
Raul MatuteRadiation Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
Angels RovirosaRadiation Oncology Department, Hospital Clínic IDIBAPS, University of Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reirradiation in gynecological cancer presents significant clinical challenges due to the complexities of prior treatments and anatomical constraints. In response to the lack of standardized protocols, a Delphi-based consensus was conducted by the GINECOR group of the Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM). A multidisciplinary panel of radiation oncologists and medical physicists developed expert-based recommendations through a structured tow-round process. Key findings emphasize the pivotal role of brachytherapy for central and vaginal recurrences and support the use of stereotactic body radiation therapy (SBRT) for nodal disease. Other modalities such as intraoperative radiotherapy and proton therapy are considered in specialized settings. The consensus highlights the importance of individualized treatment planning, especially regarding cumulative dose constraints and organ-at-risk tolerance. Futhermore, it underscores the need for further research and prospective clinical trials to refine treatment indications and optimize outcomes in this clinical context.

Indexed as

Genital Neoplasms, FemaleNeoplasm Recurrence, LocalRadiation OncologyRe-IrradiationBrachytherapyFemaleHumansRadiosurgeryRadiotherapy DosageSocieties, MedicalSpainSurvival RateBrachytherapyGynecological cancerRadiotherapyReirradiationSBRT

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.